Literature DB >> 20025791

[Skin cancer epidemic in the Netherlands].

Esther de Vries1, Tamar Nijsten, Marieke W J Louwman, Jan Willem W Coebergh.   

Abstract

Despite numerous warnings regarding the dangers of exposure to the sun, the number of skin cancer patients continues to increase rapidly. Dermatologists speak of a 'skin cancer epidemic' and estimate that the number of patients is substantially higher than the number estimated on the basis of cancer registry data. According to the Netherlands and Eindhoven cancer registries, 35.500 Dutch people were newly diagnosed with 'skin cancer' in 2006. Many skin cancer patients develop multiple skin tumours, therefore the total number of skin tumours is much higher than this. One in 6 Dutch people will develop skin cancer in their lifetime, 1 in 50 will develop a melanoma. Despite the good prognosis for most skin tumours, there is a high level of morbidity as a result of treatment. The large number of skin tumours and patients puts a great deal of pressure on the health care system.

Entities:  

Mesh:

Year:  2009        PMID: 20025791

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.

Authors:  E C Noels; L M Hollestein; S van Egmond; M Lugtenberg; L P J van Nistelrooij; P J E Bindels; J van der Lei; R S Stern; T Nijsten; M Wakkee
Journal:  Br J Dermatol       Date:  2019-04-19       Impact factor: 9.302

2.  Process evaluation of a multicentre randomised clinical trial of substituting surgical excisions of low-risk basal cell carcinomas from secondary to primary care.

Authors:  Eline Noels; Marjolein Lugtenberg; Marlies Wakkee; Kirtie H R Ramdas; Patrick J E Bindels; Tamar Nijsten; Renate R van den Bos
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

3.  Skin lesions suspected of malignancy: an increasing burden on general practice.

Authors:  Cecile J L Koelink; Boudewijn J Kollen; Feikje Groenhof; Klaas van der Meer; Wouter K van der Heide
Journal:  BMC Fam Pract       Date:  2014-02-12       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.